Avantax Planning Partners, Inc. Gsk PLC Transaction History

Avantax Planning Partners, Inc.

$2.81 Billion
Q1 2025

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$42.05 - $47.77 $11,731 - $13,327	-279 Reduced 3.74%	7,176 $312,000
Q1 2022 May 09, 2022	SELL	$40.23 - $47.74 $4,666 - $5,537	-116 Reduced 1.53%	7,455 $325,000
Q2 2021 Aug 10, 2021	SELL	$36.52 - $41.46 $7,304 - $8,292	-200 Reduced 2.57%	7,571 $301,000
Q1 2021 May 06, 2021	SELL	$34.27 - $40.01 $6,339 - $7,401	-185 Reduced 2.33%	7,771 $277,000
Q4 2020 Feb 04, 2021	SELL	$34.07 - $39.94 $1,737 - $2,036	-51 Reduced 0.64%	7,956 $293,000
Q3 2020 Oct 28, 2020	SELL	$38.11 - $42.99 $6,021 - $6,792	-158 Reduced 1.94%	8,007 $301,000
Q1 2020 Apr 27, 2020	SELL	$32.47 - $48.83 $3,084 - $4,638	-95 Reduced 1.15%	8,165 $309,000
Q4 2019 Jan 15, 2020	SELL	$42.0 - $48.25 $2,814 - $3,232	-67 Reduced 0.8%	8,260 $388,000
Q3 2019 Nov 08, 2019	SELL	$40.46 - $43.52 $3,398 - $3,655	-84 Reduced 1.0%	8,327 $355,000
Q2 2019 Aug 07, 2019	SELL	$39.4 - $42.7 $19,384 - $21,008	-492 Reduced 5.53%	8,411 $341,000
Q1 2019 May 08, 2019	BUY	$38.57 - $42.69 $125,005 - $138,358	3,241 Added 57.24%	8,903 $372,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $89,850 - $101,474	-2,377 Reduced 29.57%	5,662 $216,000
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $22,458 - $24,119	565 Added 7.56%	8,039 $323,000
Q2 2018 Aug 13, 2018	SELL	$39.61 - $42.76 $87,181 - $94,114	-2,201 Reduced 22.75%	7,474 $301,000
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $9,479 - $10,519	262 Added 2.78%	9,675 $389,000
Q4 2017 Feb 09, 2018	BUY	$35.34 - $41.9 $35 - $41	1 Added 0.01%	9,413 $334,000
Q3 2017 Oct 19, 2017	BUY	$39.44 - $41.55 $371,209 - $391,068	9,412	9,412 $382,000

Others Institutions Holding GSK

# of Institutions

Shares Held

167K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $83.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.

Account